Kyoto University to Apply for Patent Extension on iPS Cells Following Conditional Approval of Regenerative Medical Products

Kyoto University plans to seek an extension of its basic iPS cell patent by June.

The university argues Japan’s conditional approval of two iPS-based regenerative medicine products could qualify the patent for up to five more years.

The patent is a core piece of stem-cell technology linked to major regenerative medicine research and commercialization.